Foundation Medicine, Inc. (FMI) today announced that it has obtained a CE mark for FoundationOne. The CE mark allows FoundationOne to be placed on the market in the European Economic Area. In addition, Foundation Medicine has added to its growing global business partners by establishing a partnership with Barcelona, Spain-based Laboratorios LETI for the distribution of the company’s clinical products to physicians in Spain and Portugal. The company anticipates this partnership will serve as a model for similar commercial relationships with leading distributors in select markets around the world.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”